Allergan Aesthetics announced the highly anticipated national launch of JUVÉDERM® VOLUX™ XC. The long-lasting hyaluronic acid (HA) filler is now available at aesthetic practices for consumers over the age of 21 with moderate to severe loss of jawline definition. JUVÉDERM® VOLUX™ XC is the newest member of the JUVÉDERM® Collection, and offers a minimally invasive, non-surgical treatment option with minimal downtime.

In the JUVÉDERM® VOLUX™ XC clinical trial, patients reported high satisfaction with the results of their treatment.1 The JUVÉDERM® Collection is the number one chosen dermal filler collection in the U.S.8† Additionally, in a survey of aesthetic providers with experience using three or more dermal filler brands, the JUVÉDERM® brand was preferred over two times more than other dermal filler brands. Commonly reported side effects in the clinical study included tenderness, lumps/bumps, pain, swelling, firmness, bruising, redness, itching, and discoloration at the injection sites, as reported in their 30-day daily diaries.1 These side effects are consistent with HA filler injections and were usually mild (causing little discomfort and no effect on daily activities) or moderate (causing some discomfort and effect on daily activities) in severity.1 Most of these side effects went away on their own within two weeks. Consumers and new patients who receive aesthetic treatment from the JUVÉDERM® Collection of Fillers, can also enroll in Alle, the Allergan Aesthetics loyalty rewards program to unlock access to curated content, exclusive offers, and personalized rewards that can be used for savings on the Allergan Aesthetics portfolio of products and redeemed at a participating provider's office, subject to applicable program terms and conditions.

Alle is the first and only loyalty program in the aesthetics market to also offer consumers the ability to earn points on over 40 non-Allergan Aesthetics treatments and brands.